| Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells S Heink, N Yogev, C Garbers, M Herwerth, L Aly, C Gasperi, V Husterer, ... Nature immunology 18 (1), 74-85, 2017 | 376 | 2017 |
| MicroRNA loss enhances learning and memory in mice W Konopka, A Kiryk, M Novak, M Herwerth, JR Parkitna, M Wawrzyniak, ... Journal of Neuroscience 30 (44), 14835-14842, 2010 | 367 | 2010 |
| Differential loss of KIR4. 1 immunoreactivity in multiple sclerosis lesions L Schirmer, R Srivastava, SR Kalluri, S Böttinger, M Herwerth, D Carassiti, ... Annals of neurology 75 (6), 810-828, 2014 | 50 | 2014 |
| In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica‐related pathology M Herwerth, SR Kalluri, R Srivastava, T Kleele, S Kenet, Z Illes, D Merkler, ... Annals of neurology 79 (5), 794-805, 2016 | 45 | 2016 |
| D4 dopamine receptors modulate NR2B NMDA receptors and LTP in stratum oriens of hippocampal CA1 M Herwerth, V Jensen, M Novak, W Konopka, O Hvalby, G Köhr Cerebral cortex 22 (8), 1786-1798, 2012 | 29 | 2012 |
| Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: a case report M Herwerth, BJ Schwaiger, K Kreiser, B Hemmer, R Ilg Multiple Sclerosis Journal 21 (5), 666-668, 2015 | 13 | 2015 |
| A new form of axonal pathology in a spinal model of neuromyelitis optica M Herwerth, S Kenet, M Schifferer, A Winkler, M Weber, N Snaidero, ... Brain 145 (5), 1726-1742, 2022 | 12 | 2022 |
| Correction: Corrigendum: Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells S Heink, N Yogev, C Garbers, M Herwerth, L Aly, C Gasperi, V Husterer, ... Nature Immunology 18 (4), 474-474, 2017 | 7 | 2017 |
| Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated disease L Skarsta, T Nicoletti, K Frick, V Kana, A De Vere-Tyndall, M Weller, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (7), 583-585, 2023 | 4 | 2023 |
| P2R inhibitors prevent antibody-mediated complement activation in an animal model of neuromyelitis optica: P2R inhibitors prevent autoantibody injury SR Kalluri, R Srivastava, S Kenet, GK Tanti, K Dornmair, JL Bennett, ... Neurotherapeutics 19 (5), 1603-1616, 2022 | 4 | 2022 |
| Daclizumab for the treatment of relapsing-remitting multiple sclerosis M Herwerth, B Hemmer Expert Opinion on Biological Therapy 17 (6), 747-753, 2017 | 4 | 2017 |
| Axon degeneration: new actor in an old play M Herwerth, MT Wyss Neural Regeneration Research 18 (3), 547-548, 2023 | 3 | 2023 |
| Automated segmentation reveals silent radiographic progression in adult-onset vanishing white-matter disease T Huber, M Herwerth, E Alberts, JS Kirschke, C Zimmer, R Ilg The Neuroradiology Journal 30 (1), 5-9, 2017 | 2 | 2017 |
| Personalized treatment decision algorithms for the clinical implementation of serum neurofilament light chain in multiple sclerosis: a modified Delphi study P Janiaud, P Benkert, L Achtnichts, A Bar-Or, VB Lang, C Bridel, ... MULTIPLE SCLEROSIS JOURNAL 29, 961-963, 2023 | 1 | 2023 |
| Spontaneous cerebrospinal fluid leak with venous engorgement mimicking a contrast-enhancing cervical mass M Herwerth, S Prothmann, K Kreiser, B Hemmer, M Ploner JAMA neurology 73 (7), 886-887, 2016 | 1 | 2016 |
| 嘌呤能抑制剂在免疫介导疾病中的临床应用之路崎岖 MT Wyss, C Heuer, M Herwerth 中国神经再生研究 (英文版) 19 (6), 1206, 2024 | | 2024 |
| Current Issue Highlights S Palma-Florez, A Lagunas, M Mir, MT Wyss, C Heuer, M Herwerth Neural Regeneration Research 19 (6), 1165-1166, 2024 | | 2024 |
| The bumpy road of purinergic inhibitors to clinical application in immune-mediated diseases MT Wyss, C Heuer, M Herwerth Neural Regeneration Research 19 (6), 1206-1211, 2024 | | 2024 |
| Neuronal Response to In Vivo Autoimmune Astrocyte Ablation in the Mouse Cortex NB Schmid, MT Wyss, B Weber, M Herwerth GLIA 71, E605-E605, 2023 | | 2023 |
| In vivo imaging of oligodendrocyte injury in an NMO mouse model S Kenet, M Herwerth, J Bennett, B Hemmer, T Misgeld GLIA 71, E841-E842, 2023 | | 2023 |
